Trump fetal tissue ethics board urges rejection of nearly all research proposals
By Amy Goldstein,
The Washington Post
| 08. 18. 2020
A new advisory board, created to review the ethics of proposed fetal tissue research grants, is urging the Trump administration to block government funding for nearly all of the applications — essentially seeking to ban support for most such scientific work.
The recommendation that the National Institutes of Health withhold funds from all but one of a slate of 14 research proposals means that Health and Human Services Secretary Alex Azar, who has the final say, would need to buck the will of a board he convened — and of social conservatives crucial to President Trump’s political base — for the projects to get federal support.
The board sent its advice in a report to HHS on Tuesday, less than three weeks after the announcement of its members, two-thirds of whom are outspoken opponents of abortion, fetal tissue research or both. The group has operated in secrecy, with even its own members unaware of who else was in it until the end of July, when it held a single, day-long virtual meeting, most of it closed to the public...
Related Articles
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
By Jonathan D. Moreno, Hastings Center Bioethics Forum | 02.09.2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...